Dr. Steven Pipe on HEMGENIX, hemophilia B’s first gene therapy
Your browser doesn't support HTML5 audio
Dr. Steven Pipe on HEMGENIX, hemophilia B’s first gene therapy
We’ve got Dr. Steven Pipe with us to discuss the first gene therapy approved for hemophilia B, HEMGENIX. As the lead investigator of the HEMGENIX trial, Dr. Pipe details what patients need to know about HEMGENIX and what questions to consider when speaking with their hematologist. A must listen episode!
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
Connect with BloodStream Media: